Showing results (291-300 of 2,493) with videos related to
Sort By:
Pageof 250
Infection and Immunity|April 1, 1993
Experimental hematogenous candidiasis caused by Candida krusei and Candida albicans: species differences in pathogenicityE Anaissie, R Hachem, C K-Tin-U, et al.Reviews of Infectious Diseases|July 1, 1991
Infectious complications of hepatic artery catheterization procedures in patients with cancerE Wong, N Khardori, C H Carrasco, et al.Cancer Treatment Reports|December 1, 1977
Chemotherapy for metastatic carcinoid tumors: experiences with 32 patients and a review of the literatureS S Legha, M Valdivieso, R S Nelson, et al.Cancer Treatment Reports|November 1, 1979
Initial clinical studies with bruceantinA Y Bedikian, M Valdivieso, G P Bodey, et al.Cancer|July 15, 1987
Imipenem/cilastatin therapy of infections in cancer patientsG P Bodey, L Elting, P Jones, et al.Archives of Internal Medicine|July 1, 1986
Hypoprothrombinemia in patients with cancer receiving cefoperazone and mezlocillinP G Jones, S V Strother, K V Rolston, et al.Antimicrobial Agents and Chemotherapy|May 1, 1987
In vitro susceptibility of Citrobacter species to various antimicrobial agentsG Samonis, D H Ho, G F Gooch, et al.Antimicrobial Agents and Chemotherapy|April 1, 1992
In vitro activity of Ro 23-9424, a dual-action antibacterial agent, against bacterial isolates from cancer patients compared with those of other agentsK V Rolston, H T Nguyen, D H Ho, et al.Antimicrobial Agents and Chemotherapy|April 1, 1993
Comparative efficacies of cilofungin (Ly121019) and amphotericin B against disseminated Candida albicans infection in normal and granulocytopenic miceN Khardori, H Nguyen, L C Stephens, et al.Cancer|September 1, 1983
Clinical course and response to treatment of patients with acute myelogenous leukemia presenting with a high leukocyte countV Hug, M Keating, K McCredie, et al.Pageof 250